OBJECTIVE: Identifying the predictors of response to psychiatric and psychotherapeutic treatments may be useful for increasing treatment efficacy in pharmacoresistant depressive patients. The goal of this study was to examine the influence of dissociation, hope, personality trait, and selected demographic factors in treatment response of this group of patients. METHODS: Pharmacoresistant depressive inpatients were enrolled in the study. All patients completed Clinical Global Impression - both objective and subjective form (CGI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) at baseline and after 6 weeks of combined pharmacotherapy and psychotherapy (group cognitive-behavioral or group psychodynamic) treatment as an outcome measures. The Internalized Stigma of Mental Illness Scale (ISMI), Dissociative Experience Scale (DES), Adult Dispositional Hope Scale (ADHS), and Temperament and Character Inventory (TCI-R) were completed at the start of the treatment with the intention to find the predictors of treatment efficacy. RESULTS: The study included 72 patients who were hospitalized for the pharmacoresistant major depression; 63 of them completed the study. The mean scores of BDI-II, BAI, subjCGI, and objCGI significantly decreased during the treatment. BDI-II relative change statistically significantly correlated with the total ISMI score, Discrimination Experience (ISMI subscale), and Harm Avoidance (TCI-R personality trait). According to stepwise regression, the strongest factors connected to BDI-II relative change were the duration of the disorder and Discrimination Experience (domain of ISMI). ObjCGI relative change significantly correlated with the level of dissociation (DES), the total ISMI score, hope in ADHS total score, and Self-Directedness (TCI-R). According to stepwise regression, the strongest factor connected to objCGI relative change was Discrimination Experience (domain of ISMI). The existence of comorbid personality disorder did not influence the treatment response. CONCLUSION: According to the results of the present study, patients with pharmacoresistant depressive disorders, who have had more experience with discrimination because of their mental struggles, showed a poorer response to treatment.

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc; Department of Psychiatry Hospital Liberec Liberec Czech Republic

Department of Psychology Sciences Faculty of Social Science and Health Care Constantine the Philosopher University in Nitra Nitra Slovak Republic

Zobrazit více v PubMed

Tranter R, O’Donovan C, Chandarana P, Kennedy S. Prevalence and outcome of partial remission in depression. J Psychiatry Neurosci. 2002;27(4):241–247. PubMed PMC

Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012;37(4):851–864. PubMed PMC

Zhang Y, Becker T, Ma Y, Koesters M. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. BMC Psychiatry. 2014;14:245. PubMed PMC

Jacobsen PL, Mahableshwarkar AR, Serenko M, Chan S, Trivedi MH. A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder. J Clin Psychiatry. 2015;76(5):575–582. PubMed

Sueki A, Suzuki E, Takahashi H, Ishigooka J. Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine? Neuropsychiatr Dis Treat. 2016;12:1269–1273. PubMed PMC

Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995. pp. 1081–1097.

Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53:649–659. PubMed

Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(Suppl 6):16–22. PubMed

Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007;17:696–707. PubMed

Nil R, Lütolf S, Seifritz E. Residual symptoms and functionality in depressed outpatients: a one-year observational study in Switzerland with escitalopram. J Affect Disord. 2016;197:245–250. PubMed

Cloninger CR, Svrakic DM, Przybeck TR. A psychological model of temperament and character. Arch Gen Psychiatry. 1993;50:975–990. PubMed

Mulder RT, Joyce PR. Relationships of the tridimensional personality questionnaire to mood and personality measures for depressed patients. Psychol Rep. 1994;75:1315–1325. PubMed

Chien AJ, Dunner DL. The tridimensional personality questionnaire in depression: state versus trait issues. J Psychiatr Res. 1996;30:21–27. PubMed

Hansenne M, Reggers J, Pinto E, Kjiri K, Ajamier A, Ansseau M. Temperament and character inventory (TCI) and depression. J Psychiatr Res. 1999;33(1):31–36. PubMed

Richter J, Eisemann M, Richter G. Temperament and character during the course of unipolar depression among inpatients. Eur Arch Psychiatry Clin Neurosci. 2000;250:40–47. PubMed

Hirano S, Sato T, Narita T, et al. Evaluating the state dependency of the temperament and character inventory dimensions in patients with major depression: a methodological contribution. J Affect Disord. 2002;69(1–3):31–38. PubMed

Marijnissen G, Tuinier S, Sijben AES, Verhoeven WMA. The temperament and character inventory in major depression. J Affect Disord. 2002;70:219–223. PubMed

Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P. A sib-pair study of the temperament and character inventory scales in major depression. Arch Gen Psychiatry. 2003;60(5):490–496. PubMed

Smith DJ, Duffy L, Stewart ME, Muir WJ, Blackwood DH. High harm avoidance and low self-directedness in euthymic young adults with recurrent, early-onset depression. J Affect Disord. 2005;87:83–89. PubMed

Celikel FC, Kose S, Cumurcu BE, et al. Cloninger’s temperament and character dimensions of personality in patients with major depressive disorder. Compr Psychiatry. 2009;50(6):556–561. PubMed

Spittlehouse JK, Pearson JF, Luty SE, et al. Measures of temperament and character are differentially impacted on by depression severity. J Affect Disord. 2010;126(1–2):140–146. PubMed

Sasayama D, Hori H, Teraishi T, et al. Difference in temperament and character inventory scores between depressed patients with bipolar II and unipolar major depressive disorders. J Affect Disord. 2011;132(3):319–324. PubMed

Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K. Personality traits as risk factors for treatment-resistant depression. PLoS One. 2013;8(5):e63756. PubMed PMC

Joffe RT, Bagby RM, Levitt AJ, Regan JJ, Parker JD. The tridimensional personality questionnaire in major depression. Am J Psychiatry. 1993;150:959–960. PubMed

Kampman O, Poutanen O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord. 2011;135:20–27. PubMed

Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR. Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry. 1993;50:991–999. PubMed

Joyce PR, Mulder TR, Cloninger CR. Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord. 1994;30:35–46. PubMed

Kampman O, Poutanen O, Illi A, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012;27(4):245–249. PubMed

Corruble E, Duret C, Pelissolo A, Falissard B, Guelfi JD. Early and delayed personality changes associated with depression recovery? A one-year follow-up study. Psychiatry Res. 2002;109:17–25. PubMed

Nelsen MR, Dunner DL. Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res. 1995;29:43–50. PubMed

Sato T, Sakado K, Sato S, Morikawa T. Cluster a personality disorder: a marker of worse treatment outcome of major depression? Psychiatry Res. 1994;53(2):153–159. PubMed

Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry. 2006;188:13–20. PubMed

Sedlackova Z, Prasko J, Latalova K, et al. Psychosocial aspects of resistance in complex treatment of depressive disorder. Neuro Endocrinol Lett. 2015;36(4):354–362. PubMed

Russell JM, Kornstein SG, Shea MT, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry. 2003;64(5):554–561. PubMed

Kool S, Schoevers R, de Maat S, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J Affect Disord. 2005;88(3):269–278. PubMed

Blom MB, Spinhoven P, Hoffman T, et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord. 2007;104(1–3):119–126. PubMed

Maddux RE, Riso LP, Klein DN, et al. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord. 2009;117(3):174–179. PubMed

Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Can J Psychiatry. 2008;53(6):361–370. PubMed PMC

Levenson JC, Wallace ML, Fournier JC, Rucci P, Frank E. The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy. J Consult Clin Psychol. 2012;80(5):719–729. PubMed PMC

O’Leary D, Costello F. Personality and outcome in depression: an 18-month prospective follow-up study. J Affect Disord. 2001;63(1–3):67–78. PubMed

Zimmerman M, Morgan TA, Young D, Chelminski I, Dalrymple K, Walsh E. Does borderline personality disorder manifest itself differently in patients with bipolar disorder and major depressive disorder? J Pers Disord. 2015;29(6):847–853. PubMed

Galione J, Zimmerman M. A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum. J Pers Disord. 2010;24(6):763–772. PubMed

Watson S, Chilton R, Fairchild H, Whewell P. Association between childhood trauma and dissociation among patients with borderline personality disorder. Aust N Z J Psychiatry. 2006;40:478–481. PubMed

Ross CA. Borderline personality disorder and dissociation. J Trauma Dissociation. 2007;8:71–80. PubMed

American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fifth Ed (DSM-5) Arlington: American Psychiatric Association; 2013.

Dell PF, O’Neil JA. Dissociation and the Dissociative Disorders: DSM-V and Beyond. New York: Routledge; 2009.

Macrì F, Salviati M, Provenzano A, et al. Psychopathological severity index and dissociative symptomatology in a group of nonpsychotic outpatients. J Psychopathology. 2013;19:105–108.

Bob P, Freybergh PF, Jasova D, et al. Depression, cortisol and somatoform dissociative symptoms. Neuro Endocrinol Lett. 2008;29(2):235–239. PubMed

Pastucha P, Prasko J, Diveky T, et al. Dissociative disorder, and dissociation – comparison with healthy controls. Neuroendocrinol Lett. 2009;30(6):769–773. PubMed

Pastucha P, Prasko J, Diveky T, et al. Panic disorder, and dissociation – comparison with healthy controls. Neuroendocrinol Lett. 2009;30(6):774–778. PubMed

Rufer M, Fricke S, Held D, Cremer J, Hand I. Dissociation and symptom dimensions of obsessive-compulsive disorder: a replication study. Eur Arch Psychiatry Clin Neurosci. 2006;256:146–150. PubMed

Razska M, Prasko J, Koprivova J, Novak T, Adamcova K. Psychological dissociation in obsessive-compulsive disorder is associated with anxiety level but not with severity of obsessive-compulsive symptoms. Neuroendocrinol Lett. 2009;30(5):624–628. PubMed

Prasko J, Raszka M, Diveky T, et al. Obsessive-compulsive disorder and dissociation – comparison with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154(2):179–183. PubMed

Sar V, Akyüz G, Oztürk E, Alioğlu F. Dissociative depression among women in the community. J Trauma Dissociation. 2013;14(4):423–438. PubMed

Pastucha P, Prasko J, Diveky T, et al. Borderline personality disorder, and dissociation – comparison with healthy controls. Act Nerv Super Rediviva. 2009;51(3–4):146–149.

Isaac M, Chand PK. Dissociative and conversion disorders: defining boundaries. Curr Opin Psychiatry. 2006;19:61–66. PubMed

Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioral therapy in patients with the pharmacoresistant obsessive-compulsive disorder. Neuroendocrinol Lett. 2009;30(5):615–623. PubMed

Ociskova M, Prasko J, Kamaradova D, Grambal A, Latalova K, Sigmundova Z. Relationship between internalized stigma and treatment efficacy in the mixed neurotic spectrum and depressive disorders. Neuro Endocrinol Lett. 2015;35(8):711–717. PubMed

Zlotnick C, Shea MT, Zariski A, et al. Stressors and close relationships during childhood and dissociative experiences in survivors of sexual abuse among inpatient psychiatric women. Compr Psychiatry. 1995;36:207–212. PubMed

Zlotnick C, Shea MT, Pearlstein T, Simpson E, Costello E, Begin A. The relationship between dissociative symptoms, alexithymia, impulsivity, sexual abuse, and self-mutilation. Compr Psychiatry. 1996;37:12–16. PubMed

Cardena E. The domain of dissociation. In: Lynn SJ, Rhue JW, editors. Dissociation. Clinical and Theoretical Perspectives. New York: Guilford Press; 1994. pp. 15–31.

Bailer J, Witthöft M, Wagner H, Mier D, Diener C, Rist F. Childhood maltreatment is associated with depression but not with hypochondriasis in later life. J Psychosom Res. 2014;77(2):104–108. PubMed

Van Veen T, Wardenaar KJ, Carlier IV, Spinhoven P, Penninx BW, Zitman FG. Are childhood and adult life adversities differentially associated with specific symptom dimensions of depression and anxiety? Testing the tripartite model. J Affect Disord. 2013;146(2):238–245. PubMed

Huh HJ, Kim SY, Yu JJ, Chae JH. Childhood trauma and adult interpersonal relationship problems in patients with depression and anxiety disorders. Ann Gen Psychiatry. 2014;13:26. PubMed PMC

Van der Kolk BA, Pelcovitz D, Roth S, Mandel FS, McFarlane A, Herman JL. Dissociation, somatization, and affect dysregulation: the complexity of adaptation to trauma. Am J Psychiatry. 1996;153(7):83–93. PubMed

Glassman L, Weierich M, Hooley J, Deliberto T, Nock M. Child maltreatment, non-suicidal self-injury, and the mediating role of self-criticism. Behav Res Ther. 2007;45:2483–2490. PubMed PMC

Perry BP. Child maltreatment: a neurodevelopmental perspective. In: Beauchaine TP, Hinshaw SP, editors. Child and Adolescent Psychopathology. Hoboken, NJ: Wiley; 2008. pp. 93–128.

Yates TM, Carlson EA, Egeland B. A prospective study of child maltreatment and self-injurious behavior in a community sample. Dev Psychopathol. 2008;20:651–671. PubMed

Briere J, Hodges M, Godbout N. Traumatic stress, affect dysregulation, and dysfunctional avoidance: a structural equation model. J Trauma Stress. 2010;23:767–774. PubMed

Shenk CE, Noll JG, Cassarly JA. A multiple mediational tests of the relationship between childhood maltreatment and non-suicidal self-injury. J Youth Adolesc. 2010;39:335–342. PubMed PMC

Farber SK. Dissociation, traumatic attachments, and self-harm: eating disorders and self-mutilation. Clin Soc Work J. 2008;36:63–72.

Santa Mina EE. Self-harm intentions: can they be distinguished based upon a history of childhood physical and sexual abuse? Can J Nurs Res. 2010;42(4):122–143. PubMed

Bersani G, Moscariello MA, Bersani FS, et al. Dissociative symptoms in female patients with mood and anxiety disorders: a psychopathological and temperamental investigation. Eur Rev Med Pharmacol Sci. 2014;18(21):3217–3222. PubMed

Sar V, Akyuz G, Kugu N, Ozturk E, Ertem-Vehid H. Axis I dissociative disorder comorbidity in borderline personality disorder and reports of childhood trauma. J Clin Psychiatry. 2006;67:1583–1590. PubMed

Snyder CR, Harris C, Anderson JR, et al. The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol. 1991;60(4):570–585. PubMed

Snyder CR. The past and possible futures of hope. J Soc Clin Psychol. 2000;19:11–28.

Brouwer D, Meijer RR, Weekers AM, Baneke JJ. On the dimensionality of the dispositional hope scale. Psychol Assess. 2008;20:310–315. PubMed

Rand KL. Hope and optimism: latent structures and influences of grade expectancy and academic performance. J Pers. 2009;77:231–260. PubMed

Snyder CR, Sympson SC, Ybasco FC, Borders TF, Babyak MA, Higgins RL. Development and validation of the state hope scale. J Pers Soc Psychol. 1996;70:321–335. PubMed

Magaletta PR, Oliver JM. The hope construct, will, and ways: their relations with self-efficacy, optimism, and general well-being. J Clin Psychol. 1999;55:539–551. PubMed

Stanton AL, Danoff-Burg S, Cameron CL, et al. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol. 2000;68(5):875–882. PubMed

Snyder CR. Hope and depression: a light in the darkness. J Soc Clin Psychol. 2004;23:347–351.

Snyder CR, Berg C, Woodward JT, et al. Hope against the cold: individual differences in trait hope and acute pain tolerance on the cold pressor task. J Pers. 2005;73:287–312. PubMed

Arnau RC, Rosen DH, Finch JF, Rhudy JL, Fortunato VJ. Longitudinal effects of hope on depression and anxiety: a latent variable analysis. J Pers. 2006;75:43–64. PubMed

Oakley LD, Kanter JW, Taylor JY, Duguid M. The self-stigma of depression for women. Int J Soc Psychiatry. 2012;58(5):512–520. PubMed

Gaudiano BA, Miller IW. Self-stigma and attitudes about treatment in depressed patients in a hospital setting. Int J Soc Psychiatry. 2013;59(6):586–591. PubMed

Sedlackova Z, Kamaradova D, Prasko J, et al. Treatment adherence and self-stigma in patients with depressive disorder in remission – a cross-sectional study. Neuroendocrinol Lett. 2015;36(2):171–177. PubMed

Borecki L, Gozdzik-Zelazny A, Pokorski M. Personality and perception of stigma in psychiatric patients with depressive disorders. Eur J Med Res. 2010;15(Suppl 2):10–16. PubMed PMC

Mezinárodní klasifikace nemocí – 10. Revize, MKN-10 (1. vydání) Maxdorf Praha; 1996.

Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat. 1998;59(Suppl 20):22–33. quiz 34–57. PubMed

Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory – Second Edition in a sample of college students. Depress Anxiety. 2004;19(3):187–189. PubMed

Preiss M, Vacir K. Beckova sebeposuzovací škála depresivity pro dospělé – BDI-II [Beck self-report depression scale for adults – BDI-II] Brno: Psychodiagnostika; 1999.

Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: DHEW; 1976.

Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33:611–622. PubMed

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. PubMed

De Ayala RJ, Vonderharr-Carlson DJ, Kim D. Assessing the reliability of the Beck Anxiety Inventory scores. Educ Psychol Meas. 2005;65(5):742–756.

Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Inventory – comparison between diagnostic groups. Neuroendocrinol Lett. 2015;36(7):706–712. PubMed

Farmer RF, Goldberg LR. A psychometric evaluation of the revised temperament and character inventory (TCI-R) and the TCI-140. Psychol Assess. 2008;20(3):281–291. PubMed PMC

Black KJ, Sheline YI. Personality disorder scores improve with an effective pharmacology of depression. J Affect Disord. 1997;43:11–18. PubMed

Tome MB, Cloninger CR, Wason JP, Isaac MT. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997;44:101–109. PubMed

Gillespie NA, Cloninger CR, Heath AC, Martin NG. The genetic and environmental relationship between Cloninger’s dimensions of temperament and character. Pers Individ Dif. 2003;35(8):1931–1946. PubMed PMC

Preiss M, Kucharova J, Novak T, Stepankova H. The temperament and character inventory – revised (TCI-R): a psychometric characteristics of the Czech version. Psychiatr Danub. 2007;19(1–2):27–34. PubMed

Ocisková M, Sobotková I, Praško J, Mihál V. Standardization of the Czech version of the Snydeŕs Adult dispositional hope scale [Standardizace české verze Škály dispoziční naděje pro dospělé. In Czech] Psychologie a její kontexty. 2016;7(1):109–123.

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psych Res. 2003;121(1):31–49. PubMed

Ociskova M, Praško J, Kamaradova D, et al. Self-stigma in psychiatric patients – standardization of the ISMI scale. Neuroendocrinol Lett. 2014;35(7):624–632. PubMed

Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727–735. PubMed

Spitzer C, Freyberger H, Brähler E, Beutel ME, Stieglitz R. Teststatistische Überprüfung der Dissociative Experiences Scale-Taxon (DES-T) [Psychometric Evaluation of the Dissociative Experiences Scale-Taxon (DES-T)] Psychother Psychosom Med Psychol. 2015;65(3–4):134–139. German. PubMed

Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol. 1997;106(4):499–510. PubMed

Ptacek R, Bob P, Paclt I. Škála disociativních zkušeností – česká verze [Dissociative Experiences Scale – Czech version] Československa psychologie. 2006;50(3):262–272.

European Medicines Agency . Guideline for Good Clinical Practice. London, UK: European Medicines Agency; 2002. [Accessed June 17, 2015]. Available from: http://www.edctp.org/fileadmin/documents/EMEA_ICHGCP_Guidelines_July_2002.pdf.

Gorwood P, Rouillon F, Even C, Falissard B, Corruble E, Moran P. Treatment response in major depression: effects of personality. BJP. 2010;196:139–142. PubMed

Segui J, Marquez M, Garcia L, Canet J, Salvador-Carulla L, Ortiz M. Depersonalization in panic disorder: a clinical study. Compr Psychiat. 2000;41:172–178. PubMed

Gulsun M, Doruk A, Uzun O, Turkbay T, Ozsahin A. Effect of dissociative experiences on drug treatment of panic disorder. Clin Drug Investig. 2007;27:583–590. PubMed

Grace J, O’Brien JT. Association of life events and psychosocial factors with early but not late-onset depression in the elderly: implications for possible differences in etiology. Int J Geriatr Psychiatry. 2003;18:473–478. PubMed

Quilty LC, Godfrey KM, Kennedy SH, Begby RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom. 2010;79(2):116–122. PubMed

Cheng-Fang Y, Cheng-Chun C, Yu L, Tze-Chun T, Ju-Yu Y, Chih-Hung K. Self-stigma and its correlates among outpatients with depressive disorders. Psych Serv. 2005;56(5):599–601. PubMed

Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder

Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders - a cross-sectional study